Search

Your search keyword '"Sh. F. Erdes"' showing total 100 results

Search Constraints

Start Over You searched for: Author "Sh. F. Erdes" Remove constraint Author: "Sh. F. Erdes" Topic business.industry Remove constraint Topic: business.industry
100 results on '"Sh. F. Erdes"'

Search Results

2. The development of universal alopecia during therapy with TNF-α inhibitors in patients with ankylosing spondylitis: description of three cases

3. A case of effective use of interleukin 6 inhibitors in patients with ankylosing spondylitis with secondary amyloidosis

4. Progression of axial spondyloarthritis

5. Recent advances and prospects of axial spondyloarthritis / ankylosing spondylitis treatment

6. Long-term efficacy and safety of netakimab in the treatment of ankylosing spondylitis: results of Phase III international, multicenter, randomized double-blind clinical trial BCD-085-5/ASTERA

7. Efficacy and safety of netakimab, anti-IL-17A monoclonal antibody, in patients with ankylosing spondylitis. Results of phase III international, multicenter, randomized double-blind clinical trial BCD-085-5/ASTERA

8. Axial spondyloarthritis: a current look at the concept and evolution of the disease

9. Association of ankylosing spondylitis activity indicators in a Russian population of patients with STAT4 rs7574865 gene polymorphism

10. Instrumental diagnosis of coxitis in ankylosing spondylitis in real clinical practice

11. [Spondyloarthritis: modern terminology and definitions]

12. DIAGNOSIS AND TREATMENT OF COXITIS IN PATIENTS WITH ANKYLOSING SPONDYLITIS

13. JOINT DAMAGE AFTER FROSTBITE (A CASE REPORT)

14. EVALUATION OF THE PROGRESSION OF AXIAL SPONDYLOARTHRITIS IN THE EARLY STAGES OF THE DISEASE IN REAL CLINICAL PRACTICE: THE POSSIBILITIES OF USING THE SUMMARY SCORE OF RADIOGRAPHIC SACROILIITIS

15. IMPACT OF THE FREQUENCY OF USING NONSTEROIDAL ANTI-INFLAMMATORY DRUGS ON THE RADIOGRAPHIC PROGRESSION OF SACROILIITIS IN PATIENTS WITH EARLY AXIAL SPONDYLOARTHRITIS

16. SAFETY AND EFFECTIVENESS OF TRI VALENT INACTIVATED SPLIT VIRION INFLUENZA VACCINE IN PATIENTS WITH RHEUMATOID DISORD ERS

17. CLINICAL EXPERIENCE WITH ETANERCEPT IN THE TREATMENT OF PATIENTS WITH ANKYLOSING SPONDYLITIS

18. ANKYLOSING SPONDYLITIS AND PREGNANCY: DATA FROM A PILOT STUDY BASED ON A QUESTIONNAIRE SURVEY OF PATIENTS

19. REMISSION IN AXIAL SPONDYLOARTHRITIS: DEFINITION AND EVALUATION TOOLS (RECOMMENDATIONS OF THE SPONDYLOARTHRITIS STUDY GROUP OF EXPERTS, ALL-RUSSIAN PUBLIC ORGANIZATION «THE ASSOCIATION OF RHEUMATOLOGY OF RUSSIA»)

20. USE OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS AND BIOLOGICAL AGENTS FOR THE TREATMENT OF AXIAL SPONDYLOARTHRITIDES. RECOMMENDATIONS OF THE SPONDYLOARTHRITIS STUDY GROUP OF EXPERTS, ALL-RUSSIAN PUBLIC ORGANIZATION «THE ASSOCIATION OF RHEUMATOLOGY OF RUSSIA»

21. PROGRESSION OF AORTIC AND VALVULAR HEART DISEASES IN PATIENTS WITH ANKYLOSING SPONDYLITIS

22. GUIDELINES FOR THE ASSESSMENT OF DISEASE ACTIVITY AND FUNCTIONAL STATUS IN PATIENTS WITH ANKYLOSING SPONDYLITIS IN CLINICAL PRACTICE

23. Ankylosing spondylitis and non-radiographic axial spondyloarthritis: Two stages of disease?

24. DRAFT «ASPINE» MOBILE APPLICATION FOR PATIENTS WITH EARLY AXIAL SPONDYLOARTHRITIS

25. THE FREQUENCY AND SEVERITY OF EXTRASKELETAL MANIFESTATIONS OF ANKYLOSING SPONDYLITIS

26. A NEW CONCEPT OF SPONDYLOARTHRITIS: A COMPROMISE BETWEEN ASAS AND GRAPPA?

27. THE POSSIBILITIES AND RESULTS OF INDIRECT COMPARISON OF BIOLOGICAL AGENTS IN ANKYLOSING SPONDYLITIS

28. COURSE OF UVEITIS IN PATIENTS WITH ANKYLOSING SPONDYLITIS

29. INTERLEUKIN-17A IS A NEW TARGET OF ANTICYTOKINE THERAPY FOR ANKYLOSING SPONDYLITIS

30. MUSCLE RELAXANTS: ARE THEY NEEDED IN ANKYLOSING SPONDYLITIS?

31. PROBLEMS IN THE THERAPY OF AXIAL SPONDYLOARTHRITIS IN THE PROCEEDINGS OF THE EULAR CONGRESS 2015 (ROME, 10–13 JUNE 2015)

32. THE EARLY DIAGNOSIS AND CLINICAL FEATURES OF AXIAL SPONDYLOARTHRITIS AT THE EUROPEAN CONGRESS OF RHEUMATOLOGY 2015

33. USE OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS FOR THE TREATMENT OF AXIAL SPONDYLOARTHRITIS, INCLUDING ANKYLOSING SPONDYLITIS, MONITORING THEIR EFFICACY AND SAFETY (DRAFT GUIDELINES OF THE EXPERT SPONDYLOARTHRITIS DIAGNOSIS AND TREATMENT GROUP)

34. TUMOR NECROSIS FACTOR-α INHIBITORS IN THE TREATMENT OF AXIAL SPONDYLOARTHRITIS, INCLUDING ANKYLOSING SPONDYLITIS

35. CLINICAL CHARACTERISTICS OF ANKYLOSING SPONDYLITIS IN REAL PRACTICE IN RUSSIA: RESULTS OF THE CROSS-SECTIONAL NON-INTERVENTIONAL TRIAL EPICA2

36. MAGNETIC RESONANCE IMAGING DIAGNOSIS OF INFLAMMATORY CHANGES OF THE AXIAL SKELETON IN ANKYLOSING SPONDYLITIS

37. HIGH PREVALENCE OF REACTIVE ARTHRITIS IN RUSSIA: OVERDIAGNOSIS OR REALITY?

38. Impact of therapy with tumor necrosis factor-α inhibitors on the working ability of patients with ankylosing spondylitis

39. INVESTIGATION OF A ROLE OF THE IMMUNOGENICITY OF INFLIXIMAB IN THE THERAPY OF ANKYLOSING SPONDYLITIS

40. DOES BONE MINERAL DENSITY CHANGE IN EARLY AXIAL SPONDYLOARTHRITIS?

41. THE EVOLUTION OF AXIAL SPONDYLOARTHRITIS DURING 12-MONTH FOLLOW-UP STUDY OF A CORSAR COHORT

42. PROBLEMS IN THE APPLICATION OF PRINCIPLES OF EVIDENCE-BASED MEDICINE TO THE MEDICAL REHABILITATION OF RHEUMATIC DISEASES

43. ANKYLOSING SPONDYLITIS IN THE VOLGA BULGARIA

44. Efficacy of golimumab in the treatment of patients with ankylosing spondylitis (according to the data of a long-term follow-up)

45. HLA-B27-associated uveitis: From pathogenesis to therapy

46. DIAGNOSIS OF COXITIS IN ANKYLOSING SPONDYLOSIS

47. ON THE TERMINOLOGY OF SPONDYLOARTHRITIS

48. DIFFICULTIES IN THE DIAGNOSIS OF DIFFUSE IDIOPATHIC SKELETAL HYPEROSTOSIS (FORESTIER'S DISEASE)

49. [Etiopathogenetic factors of peripheral neuropathic pain in rheumatoid arthritis]

50. [Differential diagnosis between mechanical and inflammatory lower back pain, therapy options]

Catalog

Books, media, physical & digital resources